Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab

[Rinshō ketsueki] The Japanese journal of clinical hematology

Volumn 51, Issue 3, 2010, Pages 213-215

  Mimura, Naoya ^a   Kojima, Hiroshige ^a   Tsujimura, Hideki ^a   Ise, Mikiko ^a   Sakai, Chikara ^a   Fukai, Kenichi ^a   Yokosuka, Osamu ^a   Kumagai, Kyoya ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BIOLOGICAL MARKER; DRUG DERIVATIVE; ENTECAVIR; GUANINE; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB; VIRUS DNA;

AGED; ARTICLE; B CELL LYMPHOMA; BLOOD; CASE REPORT; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; MALE; MONITORING; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CARRIER STATE; DNA, VIRAL; GUANINE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, B-CELL; MALE; MONITORING, PHYSIOLOGIC; VIRUS ACTIVATION;

EID: 77952303522     PISSN: 04851439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)